Company Filing History:
2 out of 283 
1 out of 19 
1 out of 346 
Years Active: 1982-1992
Title: Antonia Jekkel Nee Bokany: Innovator in Microbial Processes
Introduction
Antonia Jekkel Nee Bokany is a notable inventor based in Budapest, Hungary. She has made significant contributions to the field of microbiology, particularly in the production of immunosuppressive antibiotics and steroid derivatives. With a total of four patents to her name, her work has had a profound impact on pharmaceutical processes.
Latest Patents
One of her latest patents is titled "Microbial process for the production of immunosuppressive antibiotics." This invention details a microbial process for producing an antibiotic complex, specifically cyclosporine A, B, and C, through the aerobic fermentation of a filamentous fungus strain. The process involves culturing a novel strain of Tolypocladium varium, which is capable of biosynthesizing these antibiotics in a nutrient-rich medium. Another significant patent is the "Microbiological process for preparing 9.alpha.-hydroxy-4-androstene-3,17-dione." This invention describes a method for producing this compound from natural sterols using a specific strain of Mycobacterium roseum, showcasing her innovative approach to biotechnological applications.
Career Highlights
Throughout her career, Antonia has worked with prominent companies in the pharmaceutical industry, including Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt. and Biogal Gyogyszergyar. Her experience in these organizations has allowed her to develop and refine her innovative processes, contributing to advancements in drug production.
Collaborations
Antonia has collaborated with esteemed colleagues such as Gabor Ambrus and Karoly Albrecht. These partnerships have fostered a collaborative environment that has enhanced her research and development efforts.
Conclusion
Antonia Jekkel Nee Bokany is a pioneering inventor whose work in microbial processes has led to significant advancements in the production of antibiotics and steroid derivatives. Her contributions continue to influence the pharmaceutical industry and inspire future innovations.